BioLizard partners with Scaler8’s explore programme to unlock novel US market opportunities
Ghent, 17th May 2023.
We are pleased to announce our partnership with Scaler8‘s Explore Programme. This collaboration marks a significant milestone for BioLizard as it sets its sights on expanding its reach and exploring new international markets.
Scaler8, renowned for its expertise in supporting startups, scaleups and SMEs, offers tailored international expansion strategies and cross-border open innovation initiatives. By joining forces with Scaler8, we aim to leverage the program’s extensive network, expert team, and mentorship resources to unlock promising market opportunities in the USA.
“The biomedical and translational research market in the USA represents a tremendous application for our scientific data analysis services and BioLizard is a powerful partner offering advanced computational and predictive biological modelling to advance therapeutic pipelines,” says Liesbeth Ceelen, Chief Executive Officer, BioLizard. “We are pleased to work with Scaler8 on our US market expansion to enable BioLizard to provide more value to its customers while supporting our goals of investment.”
As we embark on this new venture with Scaler8, it reaffirms our dedication to excellence, innovation, and strategic growth. We expect this partnership to further drive BioLizard’s expansion efforts and position us as a key player in the USA.
If you’d like to learn more about how BioLizard can help you with all your data needs, feel free to reach out. Let’s transform your data insights into impact!
